Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Financial Stress × Gynecologic × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Breast 3 Sarcoma 1 NET 1 Gynecologic 1 Genitourinary 1 Endocrine 1

Conditions

Ovarian Neoplasms 512 Uterine Cervical Neoplasms 426 Endometrial Neoplasms 272 Breast Neoplasms 120 Uterine Cervical Dysplasia 89 Neoplasms 84 Carcinoma, Ovarian Epithelial 82 Fallopian Tube Neoplasms 68 Colorectal Neoplasms 58 Lung Neoplasms 57 Uterine Neoplasms 50 Pancreatic Neoplasms 48 Papillomavirus Infections 47 Prostatic Neoplasms 46 Vulvar Neoplasms 43 Stomach Neoplasms 43 Colonic Neoplasms 41 Peritoneal Neoplasms 37 Urinary Bladder Neoplasms 34 Melanoma 33 Esophageal Neoplasms 33 Carcinoma, Non-Small-Cell Lung 33 Pelvic Neoplasms 27 Head and Neck Neoplasms 25 Rectal Neoplasms 24 Sarcoma 23 Ovarian Cysts 23 Endometrial Hyperplasia 22 Vaginal Neoplasms 21 Gynecologic Cancer 21

Interventions

Surveys and Questionnaires 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06032975 2023-11-13

MITO45-ProFFiT

National Cancer Institute, Naples

Financial Stress, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡